Paper4451975
On the control between cell-mediated, IgM and IgG immunity.
Bretscher PA. Cell Immunol, 1974. Cited by 96 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. On the control between cell-mediated, IgM and IgG immunity. Papers, record 4451975. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4451975
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigens | Major topic |
| Immunity, Cellular | Major topic |
| Immunoglobulin G | Major topic |
| Immunoglobulin M | Major topic |
| Animals | |
| Animals, Newborn | |
| Antibody Formation | |
| Binding Sites, Antibody | |
| Flagella | |
| Immune Tolerance | |
| Immunotherapy | |
| Lymphocytes | |
| Neoplasms | |
| Rats |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 96 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,328,302 | The information overload, immunology and their relationship to world health. | Open Biol | 2025 | https://conductscience.org/library/papers/40328302 | PubMed |
| 38,675,778 | Vaccines Induce Homeostatic Immunity, Generating Several Secondary Benefits. | Vaccines (Basel) | 2024 | https://conductscience.org/library/papers/38675778 | PubMed |
| 38,611,110 | A Plausible Framework Reveals Potential Similarities in the Regulation of Immunity against Some Cancers and Some Infectious Agents: Implications for Prevention and Treatment. | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38611110 | PubMed |
| 38,473,972 | Are There General Features of How Immune Responses Are Regulated That Can Provide Clues to How Remitting/Relapsing Multiple Sclerosis May Be Treated? | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38473972 | PubMed |
| 37,759,652 | What Determines the Class of Immunity an Antigen Induces? A Foundational Question Whose Rational Consideration Has Been Undermined by the Information Overload. | Biology (Basel) | 2023 | https://conductscience.org/library/papers/37759652 | PubMed |
| 36,818,971 | Implications of COVID-19 for resumption of sport in South Africa: A South African Sports Medicine Association (SASMA) position statement - Part 2. | S Afr J Sports Med | 2020 | https://conductscience.org/library/papers/36818971 | PubMed |
| 36,768,222 | The Problem of Host and Pathogen Genetic Variability for Developing Strategies of Universally Efficacious Vaccination against and Personalised Immunotherapy of Tuberculosis: Potential Solutions? | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/36768222 | PubMed |
| 36,405,696 | Analyzing some concepts of immune regulation of the last three decades: Fostering greater research resilience despite the information overload. A personal view. | Front Immunol | 2022 | https://conductscience.org/library/papers/36405696 | PubMed |
| 35,326,834 | Facing the Increased Prevalence of Antibiotic-Resistant M. tuberculosis: Exploring the Feasibility of Realising Koch's Aspiration of Immunotherapy of Tuberculosis. | Antibiotics (Basel) | 2022 | https://conductscience.org/library/papers/35326834 | PubMed |
| 31,231,378 | On Analyzing How the Th1/Th2 Phenotype of an Immune Response Is Determined: Classical Observations Must Not Be Ignored. | Front Immunol | 2019 | https://conductscience.org/library/papers/31231378 | PubMed |
| 30,825,214 | The history of the two-signal model of lymphocyte activation: A personal perspective. | Scand J Immunol | 2019 | https://conductscience.org/library/papers/30825214 | PubMed |
| 30,802,996 | Molecular model linking Th2 polarized M2 tumour-associated macrophages with deaminase-mediated cancer progression mutation signatures. | Scand J Immunol | 2019 | https://conductscience.org/library/papers/30802996 | PubMed |
| 24,684,592 | On the mechanism determining the TH1/TH2 phenotype of an immune response, and its pertinence to strategies for the prevention, and treatment, of certain infectious diseases. | Scand J Immunol | 2014 | https://conductscience.org/library/papers/24684592 | PubMed |
| 22,042,272 | Ten experiments that would make a difference in understanding immune mechanisms. | Cell Mol Life Sci | 2012 | https://conductscience.org/library/papers/22042272 | PubMed |
| 15,819,695 | Increasing the foreignness of an antigen, by coupling a second and foreign antigen to it, increases the T helper type 2 component of the immune response to the first antigen. | Immunology | 2005 | https://conductscience.org/library/papers/15819695 | PubMed |
| 15,778,511 | A biological context for the self-nonself discrimination and the regulation of effector class by the immune system. | Immunol Res | 2005 | https://conductscience.org/library/papers/15778511 | PubMed |
| 15,711,952 | The common sense of the self-nonself discrimination. | Springer Semin Immunopathol | 2005 | https://conductscience.org/library/papers/15711952 | PubMed |
| 9,874,793 | A two-step, two-signal model for the primary activation of precursor helper T cells. | Proc Natl Acad Sci U S A | 1999 | https://conductscience.org/library/papers/9874793 | PubMed |
| 9,826,349 | Mycobacterial dose defines the Th1/Th2 nature of the immune response independently of whether immunization is administered by the intravenous, subcutaneous, or intradermal route. | Infect Immun | 1998 | https://conductscience.org/library/papers/9826349 | PubMed |
| 8,945,535 | Initial route of antigen administration alters the T-cell cytokine profile produced in response to the mouse pneumonitis biovar of Chlamydia trachomatis following genital infection. | Infect Immun | 1996 | https://conductscience.org/library/papers/8945535 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/4451975
GET https://conductscience.org/api/papers/v1/4451975/cited_by?page=2